American Society of Clinical Oncology - Clinical Cancer Advances 2017

Advance of the Year: Immunotherapy 2.0

Advances in Cancer Treatment Beyond Immunotherapy

Advances in Pacient Care

Advances in Tumor Biology

Cancer Risk, Prevention, and Screening

Looking to the Future

Advances in Pacient Care - -

Artigo	Autor(es)	Referência
Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting.	Navari Rudolph M, Qin Rui, Ruddy Kathryn J, Liu Heshan, Powell Steven F, Bajaj Madhuri, Dietrich Leah, Biggs David, Lafky Jacqueline M, Loprinzi Charles L	The New England journal of medicine. 2016 Jul; 375(Jul):134-42. doi: 10.1056/NEJMoa1515725. pii: .

Nenhuma revista foi definida para este congresso.

Combined Modality Therapy	-
Longer Hormone Therapy Further Reduces Breast Cancer Recurrence	-
New Concerns About Laparoscopic Rectal Cancer Surgery	-
Targeted Therapy	-

Addressing Health Literacy in The Era of Precision Medicine	-
Better Way to Prevent Chemotherapy-Triggered Nause	-
Patient Navigation Program Improves Compliance With Cancer Therapy	-
Patient Self-Reporting of Symptoms Improves Care	-

Additional Genes Linked to Ovarian Cancer Risk	-
Broader Testing Uncovers Unexpected Cancer Predisposition Gene Mutations	-
Daily Vitamin B Reduces Skin Cancer Risk	-
Many Children With Cancer May Carry Hereditary Gene Mutations	-
New Understanding of Barriers to Cancer Screening Among Latinas	-
Pancreatic Cancer Susceptibility Genes Identified, and New Opportunities for Screening and Prevention	-

Checkpoint Inhibitors work well Against Hypermutated Cancers	-
Emerging Clues on Patient Selection	-
Progress With Immune Checkpoint Inhibitors 10	-

Expanding Targeted Therapy Options for Ovarian Cancer	-
Liquid Biopsies Help Personalize Cancer Therapy	-